EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Neuroimmunological Shifts in Disease-Modifying Therapy Use Among Multiple Sclerosis Patients: A Regional Study from Sulaymaniyah, Iraq

Zana Abdulrahman Mohammed, Sadeek Hama Aziz Salih, Savan Mohammed Dilshad Ahmed, Hazhmat Ali, Rafl Malek Kamil, Tariq Mohammad Amin, Kubra Kilic

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 10.11.2026 · 11 (2) · 293-297

DOI: 10.54133/ajms.v11i2.3387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), online erschienen am 10.11.2026. Verfasst von Zana Abdulrahman Mohammed und 6 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system with a growing global prevalence. In Iraq, diagnostic rates are increasing alongside changes in environmental exposures.

Objective

To describe the regional epidemiological burden of MS and the patterns of disease-modifying therapy (DMT) prescriptions in Sulaymaniyah, stratified by gender, age, and temporal changes in therapeutic approaches to immune-targeted treatments.

Methods

This retrospective, registry-based observational study utilized data from the Shar Hospital MS registry (2007-2025). A total of 697 confirmed MS cases were identified, of which 643 were eligible for therapeutic analysis. Extracted variables included age, sex, residential area, and prescribed DMTs. Temporal changes in DMT prescribing and associations between sex and DMT type were analyzed using chi-square tests, while age differences by sex were assessed using independent-samples t-tests.

Results

The cohort was mainly female (72.6%), with a mean age of 42.86±13 years. No significant difference in mean age was seen between sexes (p=0.60). DMT prescribing patterns changed notably over time (p

Zitieren

APA

Mohammed, Z. A., Salih, S. H. A., Ahmed, S. M. D., Ali, H., Kamil, R. M., Amin, T. M., & Kilic, K. (2026). Neuroimmunological Shifts in Disease-Modifying Therapy Use Among Multiple Sclerosis Patients: A Regional Study from Sulaymaniyah, Iraq. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 11(2), 293-297. https://doi.org/10.54133/ajms.v11i2.3387

Vancouver

Mohammed ZA, Salih SHA, Ahmed SMD, Ali H, Kamil RM, Amin TM, et al. Neuroimmunological Shifts in Disease-Modifying Therapy Use Among Multiple Sclerosis Patients: A Regional Study from Sulaymaniyah, Iraq. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2026;11(2):293-297. doi:10.54133/ajms.v11i2.3387

BibTeX
@article{Mohammed2026,
  author = {Mohammed, Zana Abdulrahman and Salih, Sadeek Hama Aziz and Ahmed, Savan Mohammed Dilshad and Ali, Hazhmat and Kamil, Rafl Malek and Amin, Tariq Mohammad and Kilic, Kubra},
  title = {Neuroimmunological Shifts in Disease-Modifying Therapy Use Among Multiple Sclerosis Patients: A Regional Study from Sulaymaniyah, Iraq},
  journal = {Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {293--297},
  doi = {10.54133/ajms.v11i2.3387}
}
Kostenlos starten →